http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Article/list/40173 Looking for medical news about skin cancer and other healthcare related topics? Modern Medicine keeps healthcare professionals well informed. 2009-11-21T21:32:07Z http://www.modernmedicine.com/modernmedicine/Gynecologic+Oncology/Nervous-System-Cancer-Linked-to-Cognitive-Impairme/ArticleNewsFeed/Article/detail/642028?contextCategoryId=40173&ref=25 Survivors of childhood central nervous system cancers are more likely to report reduced neurocognitive function resulting in lower education, employment and income in adulthood than survivors of other cancers, according to a study in the November issue of Neuropsychology. 2009-11-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642028/BRAINsmall.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642028null XML http://www.modernmedicine.com/modernmedicine/Gynecologic+Oncology/Arthritis-Drugs-Unlikely-to-Increase-Cancer-Risk/ArticleNewsFeed/Article/detail/640420?contextCategoryId=40173&ref=25 Rheumatoid arthritis patients who start taking anti-tumor necrosis factor α drugs are not likely to have a higher risk of developing cancer than other groups of rheumatoid arthritis patients, according to a Swedish study in the November issue of Arthritis & Rheumatism. 2009-11-09T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640420/ARTHRITIS.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640420null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Markers-Can-Predict-Risk-of-Melanoma-Recurrence/ArticleNewsFeed/Article/detail/639350?contextCategoryId=40173&ref=25 Levels of five markers can identify patients at high risk of recurrent melanoma who could benefit from additional treatment, according to a study published online Nov. 2 in the Journal of Clinical Oncology. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639350/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639350null XML http://www.modernmedicine.com/modernmedicine/ModernMedicine+Now/Provectus-expands-compassionate-use-for-PV-10/ArticleStandard/Article/detail/638263?contextCategoryId=40173&ref=25 National report - Provectus Pharmaceuticals has expanded its compassionate use program for PV-10, which is being developed as a therapeutic agent for metastatic melanoma and other cancers, making it available for select cancer patients in the United States, according to a press release. 2009-11-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/638263null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/ASTRO-Radiotherapy-Found-to-Be-Beneficial-in-Melan/ArticleNewsFeed/Article/detail/638658?contextCategoryId=40173&ref=25 In melanoma patients at high risk of regional relapse after lymphadenectomy, adjuvant radiotherapy may significantly improve regional control, according to research presented this week at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago. 2009-11-02T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638658/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638658null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Virus-a-culprit-Merkel-cell-pathogen-linked-to-up-/ArticleStandard/Article/detail/639564?contextCategoryId=40173&ref=25 The Merkel cell polyomavirus (MCPyV), first identified in rare aggressive Merkel cell carcinoma in 2008, has now been isolated in up to a third of patients with squamous cell carcinoma (SCC), according to a new study published online in the Journal of Investigative Dermatology. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639564null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Exercising-caution-Follicular-melanoma-remains-unk/ArticleStandard/Article/detail/639560?contextCategoryId=40173&ref=25 Folliculotropic melanoma demands timely action, as little is known about the disease's potential aggressiveness. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639560null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Protecting-hair-Novel-formulation-halts-chemothera/ArticleStandard/Article/detail/639589?contextCategoryId=40173&ref=25 A novel approach that involves using a special formulation of calcitriol proves to impart protection against chemotherapy-induced alopecia. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639589null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Skin-cancer-amp-aging-Elderly-patients-need-specia/ArticleStandard/Article/detail/639570?contextCategoryId=40173&ref=25 All patients should receive equal treatment for skin cancer, but there are important considerations when treating the elderly. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639570null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Going-molecular-Translational-research-brings-basi/ArticleStandard/Article/detail/639587?contextCategoryId=40173&ref=25 Translational research is delivering exciting results in the battle against BCC as well as pachyonychia congenita. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639587null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Slow-motion-Mohs-surgeons-tackle-difficult-to-dema/ArticleStandard/Article/detail/639571?contextCategoryId=40173&ref=25 One Mohs surgeon is successfully using the "slow Mohs" technique to treat rare melanomas that are large, invasive and amelanotic. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639571null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Recognizing-DM-Desmoplastic-melanoma-frequently-mi/ArticleStandard/Article/detail/639580?contextCategoryId=40173&ref=25 Because desmoplastic melanoma lacks a definitive clinical presentation, dermatologists often misdiagnose the disease. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639580null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lip-reconstruction-Larger-wounds-may-require-two-s/ArticleStandard/Article/detail/639557?contextCategoryId=40173&ref=25 Island pedicle flaps and advancement flaps are the mainstay of lip reconstructive surgery, but some wounds will still need something more inventive. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452009/639557null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/ACG-Bowel-Disease-Linked-to-Non-Melanoma-Skin-Canc/ArticleNewsFeed/Article/detail/636876?contextCategoryId=40173&ref=25 In patients with inflammatory bowel disease, the risk of non-melanoma skin cancer may be elevated, especially in those receiving the thiopurine class of medications, according to research presented this week at the American College of Gastroenterology Annual Scientific Meeting, held from Oct. 23 to 28 in San Diego. 2009-10-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/636876/skincancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/636876null XML http://www.modernmedicine.com/modernmedicine/Gynecologic+Oncology/Neonatal-Outcomes-Examined-in-Cancer-Pregnancies/ArticleNewsFeed/Article/detail/636218?contextCategoryId=40173&ref=25 Pregnancies in women with cancer tend to have good outcomes overall, but have been associated with high rates of induced labor and newborn admission to a neonatal intensive care unit, according to a study published online Oct. 19 in the Journal of Clinical Oncology. 2009-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636218/hospital_room.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636218null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Medical-Resident-Skin-Cancer-Exam-Training-Evaluat/ArticleNewsFeed/Article/detail/635636?contextCategoryId=40173&ref=25 Medical students and residents do not get consistent access to training in how to conduct a skin cancer examination, and need more education on how to look for skin cancer during routine medical examinations, according to a study published in the October issue of the Archives of Dermatology. 2009-10-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/635636/skincancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/635636null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Studies-shows-skin-cancer-can-be-inherited/ArticleStandard/Article/detail/634452?contextCategoryId=40173&ref=25 New York — Several studies published in the Journal of Investigative Dermatology suggest that skin cancers run in families, Reuters reports. 2009-10-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/422009/634452null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/MelaFind-Novel-instrument-performs-impressively-in/ArticleStandard/Article/detail/632446?contextCategoryId=40173&ref=25 A novel instrument for evaluating pigmented lesions is useful, a study finds. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/412009/632446null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cancer-management-Research-suggests-a-growing-role/ArticleStandard/Article/detail/632452?contextCategoryId=40173&ref=25 Medical therapy can be an important option for primary treatment of nonmelanoma skin cancer in some patients. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/412009/632452null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Targeting-melanoma-Researchers-study-tumor-specifi/ArticleStandard/Article/detail/632460?contextCategoryId=40173&ref=25 Researchers at the University of Texas Southwestern Medical Center are among those studying a new antigen in hopes of developing a vaccine against melanoma 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/412009/632460null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vitamin-D-Study-shows-intake-does-not-affect-melan/ArticleStandard/Article/detail/632458?contextCategoryId=40173&ref=25 The intake of vitamin D does not influence the risk of developing melanoma, a study shows. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/412009/632458null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vitamin-D-Supplementation-Helps-Avert-Melanoma-Rel/ArticleNewsFeed/Article/detail/628500?contextCategoryId=40173&ref=25 Vitamin D supplementation may help prevent melanoma relapse and increase the chance that tumors will be thinner if relapse does occur, according to research published online Sept. 21 in the Journal of Clinical Oncology. 2009-09-22T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/628500/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/628500null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Tanning-May-Put-Very-Light-Skinned-Youth-at-Higher/ArticleNewsFeed/Article/detail/628120?contextCategoryId=40173&ref=25 Very-light-skinned children who tan develop more nevi than their counterparts who do not, which may indicate increased risk of developing melanoma when they are older, according to a study published in the September issue of the Archives of Dermatology, while another study in the same issue recommends more states implement controls on youth access to tanning facilities. 2009-09-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/628120/tanningbed.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/628120null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Cancer-Drug-Targets-Hedgehog-Signaling-Pathway/ArticleNewsFeed/Article/detail/623798?contextCategoryId=40173&ref=25 A new drug, GDC-0449, that targets the hedgehog pathway has shown promise in the treatment of basal-cell cancer and medulloblastoma, according to two reports and an editorial published online Sept. 2 in the New England Journal of Medicine. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623798/29008.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623798null XML http://www.modernmedicine.com/modernmedicine/E-newsletter/Study-Primary-cilia-activity-may-mediate-skin-canc/ArticleStandard/Article/detail/623229?contextCategoryId=40173&ref=25 San Francisco — New research suggests that primary cilia can either promote or suppress certain types of skin cancer, depending on the mutation triggering the disease, according to a study published in Nature Medicine. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/623229null HTML http://www.modernmedicine.com/modernmedicine/Oncology+Cover/Molecular-testing-Multimarker-assay-demonstrates-h/ArticleStandard/Article/detail/622692?contextCategoryId=40173&ref=25 A multimarker assay analyzing the intensity and distribution of expression of five proteins in malignant melanoma has demonstrated high diagnostic accuracy. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/622692/molecular_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Temperature-response-New-concepts-in-telethermomet/ArticleStandard/Article/detail/622606?contextCategoryId=40173&ref=25 Findings from a study using dynamic area telethermometry to assess skin temperature kinetics of BCC suggests new approaches for monitoring and improving responses to topical therapy. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/622606null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/A-legion-of-lesions-Older-patients-commonly-presen/ArticleStandard/Article/detail/622591?contextCategoryId=40173&ref=25 Multiple basal cell carcinomas of several different types can also occur in the same patient, as seen in a recent case study. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/622591null XML http://www.modernmedicine.com/modernmedicine/Dermatology/NeoGenomics-Abbot-partner-to-develop-melanoma-test/ArticleStandard/Article/detail/622968?contextCategoryId=40173&ref=25 Ft. Myers, Fla. — NeoGenomics, a provider of cancer genetics testing services, announced that it has entered into a Strategic Supply Agreement with Abbott. The agreement provides for Abbott to supply materials for NeoGenomics to develop its own FISH (fluorescence in situ hybridization)-based test for the diagnosis of melanoma. 2009-08-31T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/622968null HTML http://www.modernmedicine.com/modernmedicine/Dermatology/Head-case-Mohs-scalp-excisions-require-refined-tou/ArticleStandard/Article/detail/622334?contextCategoryId=40173&ref=25 Mohs surgery of the scalp requires careful excision, tissue processing and closures, keeping in mind the intricacies of scalp anatomy, an expert says. 2009-08-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/352009/622334null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Oncology/Head-case-Mohs-scalp-excisions-require-refined-tou/ArticleStandard/Article/detail/621593?contextCategoryId=40173&ref=25 Mohs surgery of the scalp requires careful excision, tissue processing and closures, keeping in mind the intricacies of scalp anatomy, an expert says. 2009-08-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/352009/621593null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Most-Melanomas-Found-Are-Dermatologist-Initiated/ArticleNewsFeed/Article/detail/620721?contextCategoryId=40173&ref=25 Routine full-body skin checks by dermatologists detect more melanomas at an earlier stage than investigations as a result of patient complaints, according to a study in the August issue of the Archives of Dermatology. 2009-08-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620721/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620721null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antioxidant-Supplements-Do-Not-Appear-to-Raise-Mel/ArticleNewsFeed/Article/detail/620438?contextCategoryId=40173&ref=25 Intake of multivitamin and antioxidant supplements, including those containing selenium and beta-carotene, has no impact on the risk of developing melanoma, according to a study in the August issue of the Archives of Dermatology. The findings refute those of the Supplementation in Vitamins and Mineral Antioxidants (SUVIMAX) study, which found antioxidants increased the risk of melanoma four-fold in women. 2009-08-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620438/vitamin_e.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620438null XML http://www.modernmedicine.com/modernmedicine/Dermatology/Marginally-better-Larger-margins-should-be-new-sta/ArticleStandard/Article/detail/617317?contextCategoryId=40173&ref=25 Surgical margins for standard excision should include 9 mm of normal-appearing skin for melanoma in situs, according to a recent study. 2009-08-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/617317null HTML http://www.modernmedicine.com/modernmedicine/Dermatology/Nevi-of-special-site-Conservative-treatment-approa/ArticleStandard/Article/detail/616626?contextCategoryId=40173&ref=25 Nevi of special site can be seen not only in children and adolescents, but in adults up to age 35 as well, according to a recent study. A conservative approach to treating these nevi is justified given they do not appear to have the potential for malignancy. 2009-08-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616626null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Novel-melanoma-treatment-Preliminary-study-shows-h/ArticleStandard/Article/detail/616235?contextCategoryId=40173&ref=25 High response rates and regression of metastatic lesions were observed in preliminary study results. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616235null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Healing-light-PDT-used-to-treat-multiple-BCCs-on-b/ArticleStandard/Article/detail/616254?contextCategoryId=40173&ref=25 Several noninvasive therapeutic approaches can be used to treat superficial basal cell carcinoma. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616254null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ozone-imperils-skin-Exposure-increases-risk-of-car/ArticleStandard/Article/detail/616255?contextCategoryId=40173&ref=25 Human skin cells exposed to the ozone in smog exhibit changes in signaling pathways that put them at increased risk for developing cancer. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616255null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Atypical-presentations-SLNB-may-be-warranted-to-ru/ArticleStandard/Article/detail/616236?contextCategoryId=40173&ref=25 A recent study shows that nodal nevi do occur in the setting of Spitz nevi. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616236/Atypical_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/UV-Tanning-Beds-Classified-as-Human-Carcinogen/ArticleNewsFeed/Article/detail/615759?contextCategoryId=40173&ref=25 Ultraviolet tanning beds should be considered carcinogenic, according to a World Health Organization working group writing in the August issue of The Lancet Oncology. 2009-07-31T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/615759/tanningbed.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/615759null XML http://www.modernmedicine.com/modernmedicine/E-newsletter/Study-Athletes-at-higher-risk-for-developing-skin-/ArticleStandard/Article/detail/608540?contextCategoryId=40173&ref=25 Rosemont, Ill. - Athletes may be at higher risk for developing skin cancer, according to a recent literature study published in Sports Health: A Multidisciplinary Approach. 2009-07-07T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/608540null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Tanning-amp-teens-States-seek-to-bar-minors-from-u/ArticleStandard/Article/detail/607918?contextCategoryId=40173&ref=25 With the rate of skin cancers on the rise among the general population, public health organizations, doctors and state lawmakers are mounting increasing efforts to regulate use of tanning salons by young people. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607918null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Microsphere-based-5-FU-treatment-Multicenter-study/ArticleStandard/Article/detail/607903?contextCategoryId=40173&ref=25 A multicenter, open-label study evaluated the efficacy and safety of a proprietary microsphere-based 0.5 percent 5-fluorouracil cream (Carac, Dermik) to treat actinic keratoses on multiple body sites. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607903null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lowering-the-risk-High-serum-levels-of-vitamin-D3-/ArticleStandard/Article/detail/607896?contextCategoryId=40173&ref=25 Patients with the highest quintile levels of the active form of vitamin D (>30 ng/ml) in the blood had a 40 percent reduced risk of skin cancers compared with those in the lowest quintile (<16 ng/ml), according to a recent study. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607896null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Differential-diagnosis-Histologic-features-of-amel/ArticleStandard/Article/detail/607921?contextCategoryId=40173&ref=25 Amelanotic melanoma can have many varied, ambiguous histological features. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607921null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hedgehog-inhibitor-Vitamin-D3-shows-promise-as-top/ArticleStandard/Article/detail/607912?contextCategoryId=40173&ref=25 Research focusing on elucidating the molecular events involved in the Hedgehog (Hh) signaling pathway created interest in vitamin D3 as a chemopreventive agent for basal cell carcinoma (BCC), a tumor associated with aberrant Hh signaling. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607912null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Extensive-SCC-Unusual-case-poses-challenges-in-del/ArticleStandard/Article/detail/607926?contextCategoryId=40173&ref=25 A young adult patient presented with an extensive forehead plaque of long-standing origin that was diagnosed by biopsy to be superficially invasive squamous cell carcinoma arising from actinic keratosis. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607926null XML http://www.modernmedicine.com/modernmedicine/Dermatology/Evolution-of-Mohs-General-surgerys-loss-is-dermato/ArticleStandard/Article/detail/607891?contextCategoryId=40173&ref=25 Although invented by a general surgeon, Mohs micrographic surgery has become dermatology's gold standard for treating a variety of common nonmelanoma skin cancers. Indirectly, it has helped launch the fields of reconstructive surgery and æsthetic procedural dermatology, experts say. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607891null XML http://www.modernmedicine.com/modernmedicine/Dermatology/Multiple-AKs-and-SCCs-require-multifaceted-approac/ArticleStandard/Article/detail/607178?contextCategoryId=40173&ref=25 Without definitive answers for treating large numbers of AKs and SCCs on the legs, an expert recommends trying multiple modalities while monitoring for invasive SCC. 2009-06-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607178null HTML http://www.modernmedicine.com/modernmedicine/Dermatology/Long-term-AK-clearance-Topical-imiquimod-outperfor/ArticleStandard/Article/detail/607167?contextCategoryId=40173&ref=25 Analysis of a recent trial shows that topical imiquimod outperforms cryotherapy and topical 5-FU in terms of clinical and cosmetic outcomes in patients with actinic keratoses 12 months after treatment, an expert says. 2009-06-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607167null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Macrophage-Marker-Linked-to-Survival-in-Melanoma/ArticleNewsFeed/Article/detail/604742?contextCategoryId=40173&ref=25 Levels of a protein shed from anti-inflammatory macrophages and the level of macrophage infiltration into the tumor are associated with survival in patients with melanoma, according to a study published online June 15 in the Journal of Clinical Oncology. 2009-06-18T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/604742/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/604742null XML http://www.modernmedicine.com/modernmedicine/Dermatology/Public-supports-laws-to-help-protect-teens-from-ta/ArticleStandard/Article/detail/601452?contextCategoryId=40173&ref=25 An overwhelming number of Americans believe young adults and children should not have access to tanning salons without parental oversight because of the danger of skin cancer, suggests an online poll by www.dermanetwork.org 2009-06-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/232009/601452null HTML http://www.modernmedicine.com/modernmedicine/E-newsletter/Scientists-ID-molecules-responsible-for-melanoma-s/ArticleStandard/Article/detail/600519?contextCategoryId=40173&ref=25 International report ? Researchers at the University of Nebraska Medical Center have discovered that a superfamily of molecules causes the progression and spread of melanoma. The study results are published in the British Journal of Cancer. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/222009/600519null HTML http://www.modernmedicine.com/modernmedicine/Laser+%26+Light+Technology+in+Dermatology+Top+Story/The-power-of-light-Current-PDT-modalities-invaluab/ArticleStandard/Article/detail/600522?contextCategoryId=40173&ref=25 Photodynamic therapy is extremely effective in the treatment of actinic keratosis, and in many ways, is surpassing other currently used treatment modalities; however, more studies need to be conducted in order to maximize PDT's therapeutic effects and increase patient tolerance, while minimizing adverse events, an expert says. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/222009/600522null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Residual-SCC-Surgery-still-indicated-in-patients-w/ArticleStandard/Article/detail/601112?contextCategoryId=40173&ref=25 An ongoing study shows that biopsy-confirmed Squamous cell carcinoma in situ lesions that appear tumor-free on clinical exam may still harbor residual disease. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/232009/601112null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Out-from-under-the-knife-Therapies-available-to-tr/ArticleStandard/Article/detail/601110?contextCategoryId=40173&ref=25 Whether using a scalpel, topical cream or other therapeutic approach, derms can treat cutaneous premalignant and malignant lesions effectively. Though topical modalities such as imiquimod have inferior total clearance rates when compared to surgical approaches, in certain situations, imiquimod can sometimes prove to be the treatment of choice. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/232009/601110null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Chemoprevention-update-ALA-PDT-with-pre-treatment-/ArticleStandard/Article/detail/601118?contextCategoryId=40173&ref=25 The treatment of actinic keratosis (AK) with ALA- and MAL-PDT is effective, and according to one expert, the combination of this modality with 5-FU before PDT achieves superior AK lesion clearance rates when compared to other treatments. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/232009/601118null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ounce-of-prevention-Low-dose-oral-isotretinoin-may/ArticleStandard/Article/detail/601117?contextCategoryId=40173&ref=25 A recent study shows that oral isotretinoin is only slightly effective in the treatment of photoaging; however, the systemic retinoid proves to be significantly effective in the potential prevention of precancerous and cancerous skin lesions. According to one expert, dermatologists should carefully weigh the pros and cons of this drug before recommending it for chemoprevention. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/232009/601117null XML http://www.modernmedicine.com/modernmedicine/E-newsletter/Actinic-keratoses-have-intermittent-expression/ArticleStandard/Article/detail/600515?contextCategoryId=40173&ref=25 Montreal ? Actinic keratoses (AKs) present with intermittent expression, even in patients with extensive damage, according to an 11-month study presented at the recent Society for Investigative Dermatology meeting. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/222009/600515null HTML http://www.modernmedicine.com/modernmedicine/Dermatology/ASGT-12th-Annual-Meeting-Modified-herpes-virus-may/ArticleStandard/Article/detail/600378?contextCategoryId=40173&ref=25 A herpes virus better known for causing cold sores has shown promise as a treatment for late-stage skin cancer, according to research presented at the American Society of Gene Therapy?s 12th Annual Meeting, May 27. 2009-05-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/222009/600378null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Interferon-Reduces-Quality-of-Life-for-Advanced-Me/ArticleNewsFeed/Article/detail/598032?contextCategoryId=40173&ref=25 Patients with advanced melanoma who are treated with pegylated interferon-alfa-2b have an improvement in recurrence-free survival but a reduction in quality of life compared with observation alone, according to a study published online May 11 in the Journal of Clinical Oncology. 2009-05-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/202009/598032/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/202009/598032null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Photodynamic-therapy-systems-Doctors-face-off-on-p/ArticleStandard/Article/detail/596302?contextCategoryId=40173&ref=25 The use of photodynamic therapy is increasing, and yet the modality hasn't made much headway in the United States as a treatment for nonmelanoma skin cancers. Two dermatologists face off on its prospects for skin cancer treatment in the United States. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596302null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Brighter-days-Derms-skincare-therapy-program-lifts/ArticleStandard/Article/detail/596300?contextCategoryId=40173&ref=25 Brighter Days, a program launched by dermatologist Donald Richey, M.D., of Chico, Calif., adds a humanitarian touch to oncology treatment protocols. The program offers personalized skincare to help patients manage the side effects of chemotherapy and radiation, in a group therapy environment. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596300null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Reducing-risks-Systemic-retinoids-useful-for-nonme/ArticleStandard/Article/detail/596323?contextCategoryId=40173&ref=25 Systemic retinoids can be used to help transplant patients, long-term phototherapy patients, and patients with cutaneous T-cell lymphoma fight skin cancer. Systemic retinoids are also used in psoriasis patients with long-term exposure to phototherapy. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596323null XML http://www.modernmedicine.com/modernmedicine/Dermatology/Hitting-where-it-hurts-Medicare-policy-change-affe/ArticleStandard/Article/detail/596293?contextCategoryId=40173&ref=25 Mohs surgeons are experiencing a drastic reduction in reimbursement due to a change in Medicare policy, and further cuts may be coming. The task for dermatologists who perform Mohs surgery is to face the fact of reduced reimbursements and work with the American College of Mohs Surgery (ACMS) to reverse these measure 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596293/skin_cancer[1specialreport]_thumbnail.jpg http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596293/82959958[1]hittingwhereithurts_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/In-the-pipeline-Researchers-look-for-imiquimod-alt/ArticleStandard/Article/detail/596320?contextCategoryId=40173&ref=25 Although Aldara (imiquimod, Graceway) is effective treatment for basal cell carcinomas and actinic keratosis, researchers are looking for alternative topicals with fewer drawbacks. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596320null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Developing-your-program-Derm-offers-advice-for-est/ArticleStandard/Article/detail/596307?contextCategoryId=40173&ref=25 Dr. Richey suggests that anyone interested in developing a Brighter Days program follow these recommendations: 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596307null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Worth-the-effort-Rewards-trump-concerns-for-Mohs-s/ArticleStandard/Article/detail/596309?contextCategoryId=40173&ref=25 Even Mohs surgeons with ample experience in detecting basal cell and squamous cell carcinomas can have difficulty detecting malignant melanocytes in frozen sections, making many apprehensive about using Mohs surgery for lentigo maligna. But proponents of the technique say the fast results and reduced rate of recurrence make Mohs well worth the effort. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596309null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Potential-AK-therapy-Ingenor-mebutate-demonstrates/ArticleStandard/Article/detail/596291?contextCategoryId=40173&ref=25 The mainstay of treatment for actinic keratoses (AKs) is liquid nitrogen, but the therapy has several disadvantages. Ingenor mebutate, a topical gel, is being investigated for its efficacy and safety as a therapy, with the most recent findings showing a significant difference in the clearance rate of AKs with the use of this gel, as well as good tolerability. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596291null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Managing-dysplastic-nevi-Early-identification-curt/ArticleStandard/Article/detail/596313?contextCategoryId=40173&ref=25 Early identification of dysplastic nevi (DM) is crucial, as patients with DM are at significantly greater risk of developing malignant melanoma. An expert advocates a DN management strategy that utilizes total cutaneous examination, total cutaneous photography and dermoscopy. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596313/3205dysplastic_nevus[1]_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lentigo-maligna-Topical-agent-option-for-malignant/ArticleStandard/Article/detail/596781?contextCategoryId=40173&ref=25 Preliminary, yet promising, outcomes in two patients suggests dual therapy involving limited surgical excision followed by topical application of imiquimod 5 percent cream (Aldara, Graceway) may be an option to consider for treating invasive malignant melanoma surrounded by lentigo maligna (LM) in patients who refuse or are not good candidates for more extensive surgery, according to researchers from the department of dermatology, Saint Louis University School of Medicine, St. Louis. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/192009/596781null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Actinic-keratosis-vagaries-Consensus-committee-add/ArticleStandard/Article/detail/596308?contextCategoryId=40173&ref=25 Research suggests that AKs are most likely early-stage superficial SCCs. The dermatology, pathology and dermatopathology communities need to change their classification or prove that AKs are distinct, an expert says. Virtually all AK research is fraught with inadequate data and lack of standardized protocols, he says. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596308null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Melanoma-Screening-Strategies-Examined/ArticleNewsFeed/Article/detail/594715?contextCategoryId=40173&ref=25 In middle-aged and older men, new strategies are needed to foster the early detection and treatment of melanoma, according to two studies published in the April issue of the Archives of Dermatology. 2009-04-22T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594715/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594715null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Getting-to-the-root-Stem-cell-findings-shed-new-li/ArticleStandard/Article/detail/592579?contextCategoryId=40173&ref=25 Recent studies shed new light on stem cells in the hair follicle, countering long-held beliefs about the follicle's inability to regenerate and providing insights on the role of hair follicle stem cells in basal cell carcinomas. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/152009/592579null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Animal-instinct-Rare-form-of-melanoma-mimics-benig/ArticleStandard/Article/detail/592581?contextCategoryId=40173&ref=25 Pigmented epithelioid melanoma (PEM) is a rare variant of melanoma that can morphologically mimic a benign blue nevus. This can pose a dangerous scenario for the unwary dermatologist, who may unknowingly diagnose a blue nevus instead of PEM, which may have catastrophic repercussions. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/152009/592581null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Solar-elastosis-Study-supports-link-between-sun-da/ArticleStandard/Article/detail/592580?contextCategoryId=40173&ref=25 Though the experts seem to be increasingly undecided as to whether exposure to ultraviolet radiation is a significant cause of melanoma, results of a recent study support the notion that solar damage is associated with the development of melanoma. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/152009/592580/200222296-001_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Speaking-out-Vitamin-D-debate-needs-dermatologists/ArticleStandard/Article/detail/592582?contextCategoryId=40173&ref=25 In response to some physicians' recommending that people increase their sun exposure, an expert says dermatologists must emphasize the message of sun safety more strongly than ever. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/152009/592582null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Many-Factors-Affect-Lymph-Node-Biopsy-in-Melanoma/ArticleNewsFeed/Article/detail/586754?contextCategoryId=40173&ref=25 The use of sentinel lymph node biopsy for clinical stage I and II melanoma is associated with socioeconomic factors, according to research published online Mar. 9 in the Journal of Clinical Oncology. 2009-03-12T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586754/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586754null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAD-Six-Factor-Model-Predicts-Melanoma-Risk/ArticleNewsFeed/Article/detail/585872?contextCategoryId=40173&ref=25 A new model suggests that six risk factors are strongly associated with melanoma and gives patients and physicians a tool to assess risk, according to research presented at the 67th Annual Meeting of the American Academy of Dermatology held Mar. 6 to 10 in San Francisco. 2009-03-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/585872/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/585872null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Lasers-in-dermatology/ArticleStandard/Article/detail/585723?contextCategoryId=40173&ref=25 San Francisco — All the attention garnered by medical lasers’ aesthetic indications has overshadowed the fact that lasers’ utility for treating medical conditions continues to grow, an expert says. 2009-03-08T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/112009/585723null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Battling-cutaneous-disease/ArticleStandard/Article/detail/585700?contextCategoryId=40173&ref=25 San Francisco — Antiangiogenic agents show early promise in treating port wine stains and a host of cutaneous diseases, an expert says. 2009-03-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585700null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Desmoplastic-melanoma/ArticleStandard/Article/detail/585688?contextCategoryId=40173&ref=25 San Francisco — Although desmoplastic melanoma represents less than 2 percent of all melanomas, dermatologists should know how to recognize and treat it, because it's frequently misdiagnosed, an expert says. 2009-03-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585688null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Lip-reconstruction/ArticleStandard/Article/detail/585687?contextCategoryId=40173&ref=25 San Francisco — Most operative wounds of the upper lip can be repaired linearly with an island pedicle flap or an advancement flap. About 10 percent of wounds, however, will need something more inventive, an expert says. 2009-03-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585687null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Tryinglsquoeverythingrsquo/ArticleStandard/Article/detail/585698?contextCategoryId=40173&ref=25 San Francisco — The difficulty of treating multiple actinic keratoses (AKs) and squamous cell carcinomas (SCCs) on the legs demands that dermatologists consider multiple modalities and monitor patients closely for invasive SCC, an expert says. 2009-03-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585698null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Longitudinal-melanonychia-Diagnosis-biopsy-and/ArticleStandard/Article/detail/585697?contextCategoryId=40173&ref=25 San Francisco — Differentiating melanonychia, selecting the appropriate biopsy when indicated and carefully handling specimens were topics of presentations Saturday at the 67th Annual Meeting of the American Academy of Dermatology here. 2009-03-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585697null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Skin-moles-may-indicate-a-higher-risk-for-eye-mela/ArticleStandard/Article/detail/585457?contextCategoryId=40173&ref=25 There may be an association between atypical moles, common moles, freckles, moles on the iris, and risk of melanoma, according to a study. 2009-03-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/102009/585457null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Examines-Caffeines-Link-to-Less-Skin-Cancer/ArticleNewsFeed/Article/detail/584235?contextCategoryId=40173&ref=25 Caffeine causes skin cells damaged by ultraviolet light to self-destruct by blocking a cellular pathway involved in regulating the cell cycle, which may explain why tea and coffee consumption is associated with lower rates of non-melanoma skin cancer, according to the results of a study published online Feb. 26 in the Journal of Investigative Dermatology. 2009-03-02T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/102009/584235/sunbather_46292.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/102009/584235null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-outcomes-Topical-agents-may-enhance-surgica/ArticleStandard/Article/detail/585623?contextCategoryId=40173&ref=25 Topical agents in combination with surgery may lead to better results. Pre-op treatment can make lesions more visible, define margins and reduce tumor size. Post-op use can reduce the amount of residual cancer. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585623null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Imiquimod-for-sBCC-Five-year-trial-shows-efficacy-/ArticleStandard/Article/detail/585633?contextCategoryId=40173&ref=25 In a recent five-year study involving superficial BCC, daily treatment with imiquimod achieved high-sustained clearance and low-recurrence rates, the study's lead author says. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585633null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ultrasound-guided-biopsy-Procedure-highly-sensitiv/ArticleStandard/Article/detail/585632?contextCategoryId=40173&ref=25 A new ultrasound-guided fine needle aspiration cytology technique used to extract cells from suspected melanoma-infiltrated sentinel lymph nodes offers a more sophisticated and very accurate clinical assessment of sentinel lymph nodes. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585632null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Melanocytic-aggregates-Melanoma-does-not-necessari/ArticleStandard/Article/detail/585631?contextCategoryId=40173&ref=25 A recent study indicates that melanoma does not necessarily develop de novo. Banal nevi demonstrating melanocytic aggregates are thought to be the precursors of melanoma. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585631null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Caffeine-may-protect-against-skin-cancer/ArticleStandard/Article/detail/583651?contextCategoryId=40173&ref=25 Seattle — New research shows why caffeine may help protect against skin cancer, HealthDay News reports. 2009-02-26T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/092009/583651null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAN-Melanoma-Family-History-Linked-to-Parkinsons-D/ArticleNewsFeed/Article/detail/581998?contextCategoryId=40173&ref=25 A family history of melanoma is associated with an increased risk of developing Parkinson's disease, according to research that will be presented April 25-May 2 at the American Academy of Neurology's 61st Annual Meeting in Seattle. 2009-02-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/581998/parkinsons.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/581998null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Social-Norms-Influence-Lifeguards-Safe-Sun-Habits/ArticleNewsFeed/Article/detail/582000?contextCategoryId=40173&ref=25 Workplace safe sun policies and participation in skin cancer prevention programs both help improve the sun protection habits of lifeguards and aquatic instructors, but social norms exert the greatest influence, researchers report in the February issue of the Archives of Dermatology. 2009-02-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582000/swimmershoulder.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582000null XML http://www.modernmedicine.com/modernmedicine/E-newsletter/Shorter-interferon-course-adequately-treats-melano/ArticleStandard/Article/detail/578499?contextCategoryId=40173&ref=25 New York - Treating patients with resected high-risk melanoma with either one month or one year of adjuvant high-dose interferon alpha-2b therapy does not significantly change relapse-free or overall survival, cancerpage.com reports. 2009-02-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578499null HTML http://www.modernmedicine.com/modernmedicine/E-newsletter/Injectible-tan-leads-to-rapidly-changing-moles-exp/ArticleStandard/Article/detail/578506?contextCategoryId=40173&ref=25 Dublin, Ireland - Melanotan, an unlicensed medicine that works by increasing the levels of melanin in a person's body after being injected, has been linked to rapidly changing moles, the Evening Herald reports. 2009-02-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578506null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Benefits-and-Harms-of-Skin-Cancer-Screening-Not-Cl/ArticleNewsFeed/Article/detail/579289?contextCategoryId=40173&ref=25 There is not enough evidence in the published research on skin cancer screening to determine the benefits and harms of whole-body examination by physicians or by self-examination, according to two articles published in the Feb. 3 issue of the Annals of Internal Medicine. 2009-02-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/062009/579289/melanoma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/062009/579289null XML http://www.modernmedicine.com/modernmedicine/E-newsletter/Resveratrol-may-treat-some-cancer-better-than-chem/ArticleStandard/Article/detail/578502?contextCategoryId=40173&ref=25 Madison, Wis. -Resveratrol may be more effective than chemotherapy in treating five cancers, and may have anti-aging effects as well as prevent heart disease, associatedcontent.com reports. 2009-02-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578502null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Radiation-therapy-Outcomes-logistics-assist-dermat/ArticleStandard/Article/detail/578216?contextCategoryId=40173&ref=25 A review of the literature, including published guidelines, and site visits to radiation oncology suites was undertaken to provide clinicians with background on indications, outcomes and practical considerations for selecting radiation therapy for the treatment of nonmelanoma skin cancers. 2009-02-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578216null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Actinic-keratoses-Experimental-topical-gel-offers-/ArticleStandard/Article/detail/578203?contextCategoryId=40173&ref=25 Ingenol mebutate is a novel approach for the treatment of actinic keratoses. This new topical approach successfully treats AKs in only two or three days, — a much shorter therapeutic regimen compared to the current readily used topical approaches, such as solaraze, 5-FU and imiquimod, and, therefore, also increases patient compliance. 2009-02-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578203null XML